US Patent Issued to ProLynx on Aug. 4 for "Slow-release cytokine conjugates" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,395, issued on Aug. 4, was assigned to ProLynx LLC (San Francisco).

"Slow-release cytokine conjugates" was invented by John A. Hangasky III (San Francisco), Samuel J. Pfaff (San Francisco) and Daniel V. Santi (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure generally relates to releasable cytokine conjugates and methods of using the same."

The patent was filed on April 24, 2020, under Application No. 17/606,687.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PT...